Category Archives: Patently BIOtech

US Court of Appeals for the Federal Circuit Issues Decision in Tafas v Dudas

Read the Decision here: http://tinyurl.com/ce6o7r Read BIO’s Comments to the US Patent and Trademark Office on Proposed Rule Changes Concerning Claims Containing Alternative Language: http://www.bio.org/ip/domestic/20071009.pdf

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Monsanto Company: “Protect Innovation”

Read Monsanto Company’s guest blog post on innovation and patent reform on Patently-O Blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests.

Patently BIOtech  |  Leave a comment  |  Email This Post

Burrill Report’s interview with BIO’s President & CEO

Check out the new podcast on patent reform from Danny Levine of Burrill & Company at the Burrill Report blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Patent reform and Re-examination

Patent reform legislation was introduced in the House and Senate last week. Tell BIO what you think of the expansion of re-examination proceedings.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,